| Literature DB >> 33077817 |
Christopher E Zwilling1,2, Adam Strang3, Evan Anderson1,2, Jennifer Jurcsisn3, Erica Johnson3, Tapas Das4, Matthew J Kuchan4, Aron K Barbey5,6,7,8,9,10,11,12.
Abstract
Achieving military mission objectives requires high levels of performance from Airmen who operate under extreme physical and cognitive demands. Thus, there is a critical need to establish scientific interventions to enhance physical fitness and cognitive performance-promoting the resilience of Airmen and aiding in mission success. We therefore conducted a comprehensive, 12-week randomized controlled trial in active-duty Air Force Airmen (n = 148) to compare the efficacy of a multimodal intervention comprised of high-intensity interval aerobic fitness and strength training paired with a novel nutritional supplement [comprised of β-hydroxy β-methylbutyrate (HMB), lutein, phospholipids, DHA and selected micronutrients including B12 and folic acid] to high-intensity interval aerobic fitness and strength training paired with a standard of care placebo beverage. The exercise intervention alone improved several dimensions of physical fitness [strength and endurance (+ 8.3%), power (+ 0.85%), mobility and stability (+ 22%), heart rate (- 1.1%) and lean muscle mass (+ 1.4%)] and cognitive function [(episodic memory (+ 9.5%), processing efficiency (+ 7.5%), executive function reaction time (- 4.8%) and fluid intelligence accuracy (+ 19.5%)]. Relative to exercise training alone, the multimodal fitness and nutritional intervention further improved working memory (+ 9.0%), fluid intelligence reaction time (- 7.7%), processing efficiency (+ 1.8%), heart rate (- 2.4%) and lean muscle mass (+ 1.5%). These findings establish the efficacy of a multimodal intervention that incorporates aerobic fitness and strength training with a novel nutritional supplement to enhance military performance objectives and to provide optimal exercise training and nutritional support for the modern warfighter.Entities:
Mesh:
Substances:
Year: 2020 PMID: 33077817 PMCID: PMC7572526 DOI: 10.1038/s41598-020-74140-7
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Demographics (n = 148).
| Demographic | Supplement | Placebo | Total sample |
|---|---|---|---|
| Female | 12% | 16% | 28% |
| Average age | 30 | 30 | 30 |
| Age SD | 5.2 | 5.4 | 5.3 |
| Age range | 20–42 | 19–44 | 19–44 |
| < 12 years | 3% | 3% | 6% |
| 12–16 years | 32% | 34% | 66% |
| > 16 years | 11% | 16% | 28% |
| Airman First Class | 6% | 3% | 9% |
| Staff Sergeant | 11% | 10% | 21% |
| Technical Sergeant | 8% | 7% | 15% |
| Major Sergeant | 1% | 4% | 5% |
| Lieutenant | 8% | 11% | 20% |
| Captain | 9% | 13% | 22% |
| Major | 2% | 4% | 6% |
| Colonel | 1% | 0% | 21% |
Percentages computed from total sample (n = 148).
SD standard deviation.
Nutritional composition of one 8-ounce placebo or nutritional supplement beverage.
| Composition | Unit | Supplement | Placebo |
|---|---|---|---|
| Energy | Kcal | 267 | 100 |
| Protein | g | 13 | 2 |
| Carbohydrates | g | 38 | 20 |
| Fat | g | 7 | 2 |
| Ca-HMB | g | 1.5 | – |
| Choline | mg | 100 | – |
| DHA | mg | 125 | – |
| Folic acid | µg | 100 | – |
| Lutein | mg | 6 | – |
| Magnesium | g | 0.1 | – |
| Phospholipid | g | 0.5 | – |
| Selenium | µg | 21 | – |
| Vitamin B1 | mg | 0.4 | – |
| Vitamin B2 | mg | 0.4 | – |
| Vitamin B3 | mg | 5.0 | – |
| Vitamin B5 | mg | 3.0 | – |
| Vitamin B6 | mg | 0.8 | – |
| Vitamin B12 | µg | 2 | – |
| Vitamin C | mg | 36 | – |
| Vitamin D | IU | 480 | – |
| Vitamin E | mg | 6.0 | – |
| Zinc | mg | 25 | – |
Tests administered for the physical fitness battery.
| Fitness domain | Brief description |
|---|---|
| Abdominal circumference (inches) | Measure hip circumference using a tape measure |
| Sled push and pull R/L (seconds) | Push (15 yards) and pull (15 yards) a 140 pound sled twice |
| Rotation smash ball R/L (inches) | Distance thrown of a heavy medicine ball |
| Weight (pounds) | Measure body weight with scale |
| Wingate upper body (Watts/kg) | Arm crank with fixed resistance for 30 seconds |
| Body fat (% body weight) | DEXA overall and segmented body composition |
| Modified Illinois agility (seconds) | Quickly complete a weaving running course |
| Pull ups | 1 minute to complete as many as possible |
| Push ups | 1 minute to complete as many as possible |
| Sit ups | 1 minute to complete as many as possible |
| Standing long jump (inches) | Best of 3 jumps from a 2-foot static position |
| VO2 max (mL/kg/min) | Measure oxygen consumption on treadmill |
| Wingate lower body (Watts/kg) | Bicycle pedal with fixed resistance for 30 seconds |
| Lateral bridge R/L (seconds) | Isometric hold until exhuastion |
| Lower Y balance test R/L | Multi-planar movement to test lower body balance |
| Supine bridge R/L (seconds) | Isometric hold until exhaustion |
| Upper Y balance test R/L | Multi-planar movement to test upper body balance |
| Diastolic blood pressure (mm Hg) | Average of 3 readings taken at rest |
| Systolic blood pressure (mm Hg) | Average of 3 readings taken at rest |
| Maximum heart rate (beats/minute) | Number of beats/minute using electronic monitor |
| Resting heart rate (beats/minute) | Number of beats/minute using electronic monitor |
| Height (inches) | Total body height |
| Leg length (inches) | Length of legs |
| DEXA overall and segmented body composition | |
‘R/L’ is an average of the right and left sides of the body.
Tests administered for the cognitive battery.
| Cognitive domain | Brief description |
|---|---|
| Immediate free recall (IFR) words | Recall as many previously seen words as possible |
| Immediate free recall (IFR) pictures | Recall as many previously seen pictures as possible |
| Keep track | Recall the last instance of a given category from a previously seen set of words |
| Paired associates (PA) immediate recall | Given one word from a pair of words previously seen, recall the other word immediately |
| Paired associates (PA) delayed recall | Given one word from a pair of words previously seen, recall the other word after a delay |
| Number series accuracy (Acc) | Identify the pattern of numbers |
| Letter series accuracy (Acc) | Identify the pattern of letters |
| Symmetry span | Hold items in memory while checking symmetry in a matrix |
| Rotation span | Hold items in memory while rotating letters |
| Stroop congruent accuracy (Acc) | Determine if the font color and word color match |
| Stroop incongruent accuracy (Acc) | Determine if the font color and word color mismatch |
| Symbol digit modalities | Use a lookup table to translate symbols into numbers |
| Number series, letter series, stroop congruent and incongruent | The amount of time to respond to each item |
Statistical results for the efficacy of the exercise plus placebo intervention.
| t-stat | |||||
|---|---|---|---|---|---|
| Power* | 3.22 | 73 | 0.001 | 0.37 | 28.1 |
| Strength and endurance* | 12.3 | 65 | 10−16 | 1.52 | 1016 |
| Mobility and stability* | 5.53 | 74 | 10−7 | 0.64 | 106 |
| Blood pressure | − 0.87 | 76 | 0.19 | 0.10 | 0.29 |
| Heart rate* | − 2.16 | 75 | 0.018 | 0.25 | 2.2 |
| Lean muscle mass* | 3.42 | 76 | 0.001 | 0.39 | 48.9 |
| Short term memory | − 2.4 | 72 | 0.99 | 0.29 | 0.04 |
| Episodic memory* | 2.4 | 55 | 0.01 | 0.32 | 3.65 |
| Fluid intelligence acc* | 5.5 | 73 | 10−7 | 0.64 | 105 |
| Fluid intelligence RT | 0.55 | 72 | 0.71 | 0.06 | 0.09 |
| Working memory | − 1.64 | 73 | 0.95 | 0.19 | 0.05 |
| Executive function acc | − 1.14 | 73 | 0.87 | 0.13 | 0.06 |
| Executive function RT* | − 3.2 | 73 | 0.0011 | 0.37 | 23.2 |
| Processing efficiency* | 2.6 | 73 | 0.005 | 0.23 | 6.4 |
| Cortisol (µg/dL)* | − 1.60 | 77 | 0.056 | 0.18 | 0.80 |
| Ferritin (ng/mL)* | − 6.58 | 76 | 10−9 | 0.75 | 106 |
| Folate (ng/mL)* | − 1.65 | 76 | 0.051 | 0.19 | 0.87 |
| High density lipoprotein (mg/dL) | 0.77 | 77 | 0.22 | 0.09 | 0.26 |
| Low density lipoprotein (mg/dL)* | − 2.33 | 77 | 0.01 | 0.26 | 3.14 |
| Lutein density in fovea | − 0.13 | 30 | 0.55 | 0.02 | 0.17 |
| Lutein density in parafovea | − 0.43 | 30 | 0.66 | 0.08 | 0.14 |
| Triglycerides (mg/dL) | − 0.19 | 76 | 0.58 | 0.02 | 0.11 |
| Vitamin B12 (pg/mL)* | − 3.36 | 76 | 0.001 | 0.38 | 40.6 |
| Saturated fatty acids (mol%) | 0.30 | 77 | 0.38 | 0.04 | 0.16 |
| Monounsaturated fatty acids (mol%) | 1.25 | 77 | 0.11 | 0.14 | 0.47 |
| Omega-3 PUFAs (mol%) | − 0.43 | 77 | 0.67 | 0.05 | 0.18 |
| Omega-6 PUFAs (mol%) | − 0.51 | 77 | 0.69 | 0.06 | 0.09 |
| Trans fatty acids (mol%) | − 1.53 | 77 | 0.06 | 0.17 | 0.71 |
t-stat is the value of the 1-sided t-statistic (where negative values represent decreases from pre- to post-intervention); df is the degrees of freedom of the t-test; p value is the frequentist p value of the t-test; d is Cohen’s d; and Bf is the Bayes factor for the t-test. An * in the row header indicates the exercise plus placebo intervention modified that indicator. PUFA stands for polyunsaturated fatty acid.
Statistical results for the efficacy of the exercise plus supplement intervention.
| t-stat | |||||
|---|---|---|---|---|---|
| Power* | 4.97 | 63 | 10−6 | 0.62 | 6324 |
| Strength and endurance* | 10.9 | 50 | 10−15 | 1.52 | 1012 |
| Mobility and stability* | 6.1 | 69 | 10−8 | 0.73 | 106 |
| Blood pressure* | − 2.7 | 69 | 0.004 | 0.33 | 7.9 |
| Heart rate* | − 6.2 | 68 | 10−8 | 0.75 | 106 |
| Lean muscle mass* | 9.2 | 69 | 10−14 | 1.10 | 1010 |
| Short term memory | − 2.2 | 63 | 0.98 | 0.27 | 0.05 |
| Episodic memory* | 2.28 | 58 | 0.013 | 0.30 | 3.05 |
| Fluid intelligence acc* | 5.3 | 65 | 10−7 | 0.65 | 104 |
| Fluid intelligence RT* | − 1.85 | 65 | 0.034 | 0.23 | 1.30 |
| Working memory* | 1.81 | 67 | 0.04 | 0.22 | 1.20 |
| Executive function acc | − 4.3 | 66 | 0.001 | 0.52 | 0.03 |
| Executive function RT* | − 5.6 | 66 | 10−7 | 0.68 | 104 |
| Processing efficiency* | 5.4 | 69 | 10−7 | 0.47 | 104 |
| Cortisol (µg/dL)* | − 1.61 | 54 | 0.057 | 0.22 | 0.92 |
| Ferritin (ng/mL)* | − 5.96 | 54 | 10−8 | 0.80 | 105 |
| Folate (ng/mL)* | 1.74 | 54 | 0.043 | 0.24 | 1.15 |
| High density lipoprotein (mg/dL) | 1.04 | 54 | 0.15 | 0.14 | 0.41 |
| Low density lipoprotein (mg/dL)* | − 2.54 | 54 | 0.007 | 0.35 | 5.45 |
| Lutein density in fovea* | 1.62 | 13 | 0.06 | 0.43 | 1.42 |
| Lutein density in parafovea | 1.07 | 13 | 0.15 | 0.29 | 0.73 |
| Triglycerides (mg/dL) | 1.25 | 54 | 0.11 | 0.17 | 0.54 |
| Vitamin B12 (pg/mL)* | 2.02 | 54 | 0.024 | 0.27 | 1.89 |
| Saturated fatty acids (mol%) | 0.24 | 55 | 0.41 | 0.04 | 0.18 |
| Monounsaturated fatty acids (mol%) | − 0.15 | 55 | 0.56 | 0.02 | 0.13 |
| Omega-3 PUFAs (mol%)* | 6.72 | 55 | 10−9 | 0.90 | 106 |
| Omega-6 PUFAs (mol%)* | − 3.52 | 55 | 0.00043 | 0.47 | 62.2 |
| Trans fatty acids (mol%) | − 0.86 | 55 | 0.20 | 0.11 | 0.33 |
t-stat is the value of the 1-sided t-statistic (where negative values represent decreases from pre- to post-intervention); df is the degrees of freedom of the t-test; p value is the frequentist p value of the t-test; d is Cohen’s d; and Bf is the Bayes factor for the t-test. An * in the row header indicates the exercise plus placebo intervention modified that indicator. PUFA stands for polyunsaturated fatty acid.
Statistical results comparing the efficacy of the unimodal exercise plus placebo intervention to the multimodal exercise plus supplement intervention.
| F-stat | |||||
|---|---|---|---|---|---|
| Power | 1.46 | (2,135) | 0.23 | 0.20 | 0.35 |
| Strength and endurance | 1.80 | (2,114) | 0.18 | 0.22 | 0.48 |
| Mobility and stability | 0.05 | (2,142) | 0.82 | 0.04 | 0.18 |
| Blood pressure | 0.75 | (2,144) | 0.39 | 0.14 | 0.48 |
| Heart rate* | 7.42 | (2,142) | 0.007 | 0.45 | 7.03 |
| Lean muscle mass* | 13.9 | (2,144) | 0.0003 | 0.61 | 63.4 |
| Episodic memory | 1.77 | (2,115) | 0.19 | 0.22 | 0.14 |
| Fluid intelligence acc | 0.27 | (2,140) | 0.60 | 0.09 | 0.20 |
| Fluid intelligence RT* | 2.28 | (2,139) | 0.13 | 0.25 | 2.09 |
| Working memory* | 6.81 | (2,142) | 0.01 | 0.43 | 8.27 |
| Executive function RT | 0.99 | (2,141) | 0.32 | 0.16 | 0.53 |
| Processing efficiency* | 3.12 | (2,141) | 0.08 | 0.29 | 1.07 |
| Cortisol (µg/dL) | 0.04 | (2,129) | 0.84 | 0.03 | 0.21 |
| Low density lipoprotein (mg/dL) | 0.13 | (2,129) | 0.72 | 0.06 | 0.21 |
| Ferritin (ng/mL) | 0.30 | (2,129) | 0.59 | 0.09 | 0.27 |
| Folate (ng/mL)* | 14.6 | (2,129) | 0.0002 | 0.66 | 2.65 |
| Lutein density in fovea | 0.48 | (2,42) | 0.49 | 0.12 | 0.49 |
| Vitamin B12 (pg/mL)* | 16.5 | (2,129) | 10−5 | 0.70 | 79.9 |
| Omega-3 PUFAs (mol%)* | 46.1 | (2,131) | 10−16 | 1.18 | 107 |
| Omega-6 PUFAs (mol%)* | 6.7 | (2,131) | 0.011 | 0.45 | 5.93 |
F-stat is the value of the ANCOVA model which included group as a factor and pre-intervention performance as a covariate; df is the degrees of freedom of the ANCOVA model; p value is the frequentist p value of the ANCOVA model; d is Cohen’s d; and Bf is the Bayes factor for the ANCOVA. An * in the row header means the exercise plus supplement intervention improved that indicator more than the exercise plus placebo intervention. To minimize the number of analyses conducted—and the resulting Type 1 error—Table 7 only includes rows from Table 5 or 6 that had a significant result. PUFA stands for polyunsaturated fatty acid. Supplementary Table 13 lists the means underlying these statistical tests.
Figure 1Maximum heart rate for the exercise plus supplement (red line) and exercise plus placebo (blue line) interventions. The x-axis is the week of the study and the y-axis is the average maximum heart rate. Each point on the plot represents the average maximum heart rate across all participants in that intervention condition for that week.